--(BUSINESS WIRE)--Purdue Pharma is a privately-held pharmaceutical company and is part of a global network of independent associated companies that is known for pioneering research in chronic pain and opioids with abuse deterrent properties. The company’s leadership and employees are committed to serving healthcare professionals, patients and caregivers quality products and educational resources to support their proper use. Purdue Pharma is engaged in the research, development, production and distribution of both prescription and over-the-counter medicines and hospital products. With Purdue Pharma’s expertise in drug development, commercialization, and life-cycle management, the company is diversifying in high-need areas to expand through strategic acquisitions and creative partnerships. For more information please visit www.purduepharma.com or follow the company on Twitter @PurduePharma, Instagram (http://instagram.com/purduepharma) and LinkedIn (https://www.linkedin.com/company/purdue-pharma).
|
Company: |
Purdue Pharma L.P. | ||
|
Headquarters Address: |
201 Tresser Blvd. | ||
| Stamford, CT 06901 | |||
|
Main Telephone: |
9177632709 | ||
|
Website: |
|||
|
Type of Organization: |
Private | ||
|
Industry: |
Pharmaceutical | ||
|
Key Executives: |
CEO: Mark Timney |
||
|
Head of Licensing & Business Development: Alan Butcher |
|||
|
Head of Research & Development: Alan Dunton |
|||
|
Public Relations |
|||
|
Contact: |
Catherine London | ||
|
Phone: |
203-588-7530 | ||
|
Email: |
|||
|
Public Relations |
|||
|
Contact: |
Bob Josephson | ||
|
Phone: |
203-588-7114 | ||
|
Email: |
|||
|
Public Relations |
|||
|
Contact: |
Raul Damas | ||
|
Phone: |
203-588-7600 | ||
